Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 198.50
-4.40 (-2.17%)
At close: Mar 2, 2026
Getinge AB Market Cap
Getinge AB has a market cap or net worth of 55.26 billion as of March 2, 2026. Its market cap has decreased by -4.52% in one year.
Market Cap
55.26B
Enterprise Value
62.81B
Revenue
34.97B
Ranking
n/a
PE Ratio
24.47
Stock Price
198.50
Market Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 15.22B to 55.26B, an increase of 263.19%. That is a compound annual growth rate of 4.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 55.26B | -7.27% |
| Dec 30, 2025 | 59.59B | 20.52% |
| Dec 30, 2024 | 49.45B | -19.06% |
| Dec 29, 2023 | 61.09B | 3.70% |
| Dec 30, 2022 | 58.91B | -45.25% |
| Dec 30, 2021 | 107.61B | 105.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 37.34B |
| Elekta AB | 22.18B |
| Nolato AB | 14.02B |
| Vitrolife AB | 12.92B |
| MedCap AB | 7.35B |
| Xvivo Perfusion AB | 5.91B |
| CellaVision AB | 3.62B |
| BICO Group AB | 1.29B |